Previous Page  11 / 22 Next Page
Information
Show Menu
Previous Page 11 / 22 Next Page
Page Background

Page 55

allied

academies

Current Pediatric Research| Volume: 22

November 28-29, 2018 | Dubai, UAE

15

th

World Congress on

Pediatrics, Clinical Pediatrics and Nutrition

28

th

International Conference on

Nursing Practice

Joint Event

&

Clostridium difficile: Environmental controls and testing methodology redesign to reduce incidence in an

acute care setting

Jacqueline Whitaker

Florida Hospital Tampa, USA

C

lostridium difficile was discovered in 1935, but it was

not recognized as a cause of antibiotic associated

diarrhea until 1974 when a “clindamycin-associated colitis”

was identified. Research beginning in 1978 determined

the following: (1) cytotoxin assay as the preferred method

for diagnosis; (2) clindamycin was the common inducing

agent; (3) identified toxin A (“enterotoxin”) and toxin B

(“cytotoxin”); (4) confirmed the age-associated risk; (5)

identified acute and chronic care facilities are high risk; and

(6) established oral vancomycin as the treatment of choice.

During the 21st century a more rapid detection method was

developed, the real-time polymerase chain reaction (PCR) test.

With the advent of the PCR test, the specificity and sensitivity

were maintained, but the turnaround of the diagnostic test

result was measured in hours as compared to days for a cell

cytotoxicity test via tissue culture. Combined with patient

symptoms, providers could confirm presence of the genetic

code for C. difficile toxins from stool samples through use of

the PCR test. This provided clinicians with a rapid, specific and

sensitive diagnostic test to prescribe definitive antimicrobial

treatment versus empiric antimicrobial treatment to patients.

There is no single recommended testing methodology or

algorithm for C. difficile currently. When our hospital converted

to the use the C. difficile PCR test as a single diagnostic tool,

we saw an increase in the number of healthcare associated

test results reported due to the C difficile PCR test. With

the potential for increased utilization of antimicrobials for

colonization versus active disease, some hospitals have chosen

to use a combination of antigen and toxin test methodologies

with the PCR test reserved for discrepant test results.

Our hospital converted to the Cepheid Xpert C. difficile assay

(Sunnyvale, CA) in December 2011 as the primary method for

C. difficile identification. With the increased sensitivity and

specificity of the test results, thehospital reported an increase in

healthcareassociatedtestresultsandutilizationofantimicrobials.

As a result, the infection control program in conjunctionwith the

antimicrobial stewardship leaders developed an algorithm for

testing that included the C. difficile antigen and toxin test (PCR

test for discrepant results only), isolation and cleaning protocol

during admission and at time of discharge. An educational

program for the physicians, nursing and microbiology staff

covered the Bristol stool chart and appropriate stool type for

testing, discontinuation of stool softeners and laxatives for 48

hours, as well as the need for 3 loose, watery stools within a

24-hour period. The environmental cleaning protocol utilized

a sporicidal disinfectant on all lateral surfaces, including the

floors, during admission and at time of discharge. The use of the

UVC machine was included at time of discharge to ensure the

patient room was cleaned and disinfected for the next patient.

The instances where Nursing units have more than one positive

test results, the isolates are sent for DNA typing to determine

if there was cross transmission among the patient population.

There was a seventy five percent (75%) reduction in the

positive C diff test results with the new testing methodology.

Infectious Disease physicians can call the Laboratory for

specific requests not included in the testing algorithm.

A combination of a new testing methodology algorithm,

automated notification of patient discharge, an environmental

control program that includes a sporicidal disinfectant and the

useofUVCat timeofdischargehasallowedouracutecare facility

to maintain this reduction consistently for the last nine months.

e:

jacqueline.whitaker@ahss.org

Pediatrics and Clinical Pediatrics 2018

& Nursing Practice 2018, Volume 22

DOI: 10.4066/0971-9032-C2-006